logo-loader
RNS
viewAbbvie

Norges Bank - Form 8.3 - AbbVie Inc

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.      KEYINFORMATION

2.        INTERESTS ANDSHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Ap20

(Note 4)1.      DEALINGS

(a)      Purchases and sales

(b)      Derivatives transactions (other than options transactions)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

(ii)      Exercising

(d)          Other dealings (including transactions in respect of new securities) (Note 4)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(Note 9)                                            Is a Supplemental Form 8 attached?/NOYES

of person dealing (Note 1)                         dealt in                                       

Class of relevant security to which the dealings being  common stock
disclosed relate (Note 2)                              US00287Y1091

Date of dealingNameNorges Bank

CompanyAbbVie IncUS$0.0106/05/2020
Long     Short

                                            Number  (%) Number  (%)

(1) Relevant securities                     13,836,342
                                            (0.91%)

(2) Derivatives (other than options)        1,234,300
                                            (0.11%)

(3) Options and agreements to purchase/sell

Total                                       15,070,642
                                            (1.02%)
Class of relevant security:                    Long     Short

                                            Number  (%) Number  (%)

(1) Relevant securities


(2) Derivatives (other than options)


(3) Options and agreements to purchase/sell

Total
Purchase/sale Number of relevant securities Price per unit (Note 5)

Purchase      440,10085.4200 USD
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD      (Note 6)              (Note 7)                      (Note 5)

CFD           Sale                  440,10085.4200 USD
Product   Writing,    Number of    Exercise Type, e.g. Expiry date Option money
name,     selling,    securities   price    American,              paid/received
e.g. call purchasing, to which the          European               per unit
option    varying     option                etc.                   (Note 5)
          etc.        relates
                      (Note 7)
Product name,    Number of securities Exercise price per unit (Note 5)
e.g. call option
Nature of transaction Details Price per unit
(Note 8)                      (if applicable) (Note 5)
Date of disclosure                                       

Contact name                                             

Telephone number                                         +47 2407 3297

If a connected EFM, name of offeree/offeror with which
connected

If a connected EFM, state nature of connection (Note 10)07/05/2020Philippe Chiaroni

Quick facts: Abbvie

Price: 96.83

Market: NYSE
Market Cap: $170.65 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE